[Cod liver oil. A natural Vitamin D for preserving health]. / Csukamájolaj. Egy természetes D-vitamin az egészség megorzésére.

Vitamin D deficiency is pandemic in industrialized countries due to life-style changes. Recent studies suggest that besides bone-metabolism, vitamin D plays a central role in basic cell function like multiplication, differentiation and metabolism. This may explain that low vitamin D levels represent a risk factor for several apparently different diseases such as infective, autoimmune, neurodegenerative and cardiovascular diseases, as well as diabetes, osteoporosis and cancer. Accumulating evidences suggest that an adequate intake of vitamin D may significantly decrease prevalence and clinical outcome of these diseases. Estimated reduction of the economic burden might reach about 10 percent through normalizing vitamin D levels for these diseases. However, high doses of vitamin D monotherapy needs precaution for potential adverse effects and it should be substituted with the recommended doses of vitamin D in combination with synergistic vitamin A and omega 3 fatty acids, such as cod liver oil.

[Metabolic therapy for early treatment of age-related macular degeneration]. / Metabolikus terápia az idoskori makuladegeneráció korai kezelésére.

Currently, age-related macular degeneration is one of the most common eye diseases causing severe and permanent loss of vision. This disease is estimated to affect approximately 300-500 thousand Hungarians. While earlier no treatment was available, in the recent decade an antioxidant therapy became very popular using combinations of high dosage antioxidant vitamins C, E, beta carotene and zinc. Based on theoretical concepts and mostly in vitro experiences, this combination was thought to be effective through neutralizing reactive oxygen species. According to a large clinical trial (AREDS) it reduced progression of intermediate state disease to advanced state, but did not influence early disease. This original combination, due to potential severe side effects, is not on the market anymore. However, the efficacy of modified formulas has not been proved yet. Recently, the metabolic therapy, a combination of omega-3 fatty acids, coenzyme Q10 and acetyl-L-carnitine has been introduced for treating early age-related macular degeneration through improving mitochondrial dysfunction, specifically improving lipid metabolism and ATP production in the retinal pigment epithelium, improving photoreceptor turnover and reducing generation of reactive oxygen species. According to a pilot study and a randomized, placebo-controlled, double blind clinical trial, both central visual field and visual acuity slightly improved after 3-6 months of treatment and they remained unchanged by the end of the study. The difference was statistically significant as compared to the base line or to controls. These functional changes were accompanied by an improvement in fundus alterations: drusen covered area decreased significantly as compared to the base line or to control. Characteristically, all these changes were more marked in less affected eyes. A prospective case study on long-term treatment confirmed these observations. With an exception that after slight improvement, visual functions remained stable, drusen regression continued for years. Sometimes significant regression of drusen was found even in intermediate and advanced cases. All these findings strongly suggested that the metabolic therapy may be the first choice for treating age-related macular degeneration. Currently, this is the only combination of ingredients corresponding to the recommended daily allowance, and at the same time, which showed clinically proved efficacy.

The human choriocapillaris: evidence for an intrinsic regulation of the endothelium?

The aim of the present study was to describe the ultrastructure of particular cells observed in the microvascular bed of the healthy human choroid, in close relation to the wall of the microvessels and resembling the periadventitial cells of other vascular areas of the human body. Serial sections of 12 fresh human eyes were studied by transmission electron microscopy. In all the eyes, the sections were obtained by cutting from the same zones (inner and outer choroid at the posterior pole of the eye). Standard techniques were used for transmission electron microscopy. Round cell bodies were found in the inner choroid at the posterior pole of the eye, mainly located in the intercapillary connective tissue. The cells were composed of an electron-transparent cytoplasm containing a few small mitochondria, and a dilated smooth surface of endoplasmic reticulum, at some points continuous with the nuclear membrane. These cells showed processes forming contact with the capillary wall. Some of these processes extended to the elastic layer of Bruch's membrane, but none had contact with the retinal pigment epithelium. A thin basement membrane surrounded both the cell bodies and processes. We believe that these cells are special cells resembling some type of periendothelial cells also localized in other microvascular districts of the human body. The close topographic correlation with the endothelial cells seems to indicate that these special cells play a role in the intrinsic control of proper endothelial functions.